Citations

Mayo Clinic

Showing 10 of 108551 citations.

P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth
Gang, Xiaokun , Yang, Yinhui , Zhong, Jian , Jiang, Kui , Pan, Yunqian , Karnes, R. Jeffrey , Xu, Wanhai , Wang, Guixia , Gang, Xiaokun , Zhang, Jun , Huang, Haojie

Oncotarget | February 25, 2016 | Volume: 7 | Issue: 12 | Pages: 15135-15149

10.18632/oncotarget.7715 | PMID 26934656 Get It

Plasma cell myeloma with numerous cytoplasmic granules
Shi, Min , He, Rong , Shi, Min

Blood | February 25, 2016 | Volume: 127 | Issue: 8 | Pages: 1073-1073

10.1182/blood-2015-12-685214 | PMID 27351034 Get It

Mössbauer Studies of Pathological Brain Tissues Affected by PSP Disease
Gała̧zka‐Friedman, J. , Bauminger, E. R., Szlachta, Karol , Schweitzer, K., Friedman, A. , Wszołek, Zbigniew K. , Dickson, Dennis W.

Acta Physica Polonica A | February 25, 2016 | Volume: 115 | Issue: 2 | Pages: 545-547

10.12693/aphyspola.115.545 Get It

Appending Limited Clinical Data to an Administrative Database for Acute Myocardial Infarction Patients
Samadashvili, Zaza, Cozzens, Kimberly , Venditti, Ferdinand J. , Holmes, David R. , Berger, Peter B. , Stamato, Nicholas J., Walford, Gary, Hannan, Edward L. , Jacobs, Alice K. , Hughes, Suzanne C.

Medical Care | February 25, 2016 | Volume: 54 | Issue: 5 | Pages: 538-545

10.1097/mlr.0000000000000520 | PMID 27078825 Get It

Background: Hospitals’ risk-standardized mortality rates and outlier status (significantly higher/lower rates) are reported by the Centers for Medicare and Medicaid Services (CMS) for acute myocardial infarction (AMI) patients using Medicare claims data. New York now has AMI claims data with blood pressure and heart rate added. Objective: The objective of this study was to see whether the appended database yields different hospital assessments than standard claims data. Methods: New York State clinically appended claims data for AMI were used to create 2 different risk models based on CMS methods: 1 with and 1 without the added clinical data. Model discrimination was compared, and differences between the models in hospital outlier status and tertile status were examined. Results: Mean arterial pressure and heart rate were both significant predictors of mortality in the clinically appended model. The C statistic for the model with the clinical variables added was significantly higher (0.803 vs. 0.773, P<0.001). The model without clinical variables identified 10 low outliers and all of them were percutaneous coronary intervention hospitals. When clinical variables were included in the model, only 6 of those 10 hospitals were low outliers, but there were 2 new low outliers. The model without clinical variables had only 3 high outliers, and the model with clinical variables included identified 2 new high outliers. Conclusion: Appending even a small number of clinical data elements to administrative data resulted in a difference in the assessment of hospital mortality outliers for AMI. The strategy of adding limited but important clinical data elements to administrative datasets should be considered when evaluating hospital quality for procedures and other medical conditions.
Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate
Belcher, John D. , Chen, Chunsheng , Nguyen, Julia , Abdulla, Fuad , Nguyen, Phong , Killeen, Trevor, Xu, Pauline , O'Sullivan, Gerry, Nath, Karl A. , Vercellotti, Gregory M. , O’Sullivan, M. Gerard , Zhang, Ping , O'Sullivan, M Gerard

Antioxidants & Redox Signaling | February 25, 2016 | Volume: 26 | Issue: 14 | Pages: 748-762

10.1089/ars.2015.6571 | PMID 26914345 Get It

Aims: Heme derived from hemolysis is pro-oxidative and proinflammatory and promotes vaso-occlusion in murine models of sickle cell disease (SCD), suggesting that enhanced detoxification of heme may be beneficial. Nuclear factor erythroid-2-related factor-2 (Nrf2) transcription pathway is the principal cellular defense system responding to pro-oxidative and proinflammatory stress. Dimethyl fumarate (DMF), a drug approved for treatment of multiple sclerosis, provides neuroprotection by activating Nrf2-responsive genes. We hypothesized that induction of Nrf2 with DMF would be beneficial in murine SCD models. Results: DMF (30 mg/kg/day) or vehicle (0.08% methyl cellulose) was administered for 3–7 days to NY1DD and HbSS-Townes SCD mice. Vaso-occlusion, a hallmark of SCD, measured in sickle mice with dorsal skinfold chambers, was inhibited by DMF. The inhibitory effect of DMF was abrogated by the heme oxygenase-1 (HO-1) inhibitor tin protoporphyrin. DMF increased nuclear Nrf2 and cellular mRNA of Nrf2-responsive genes in livers and kidneys. DMF increased heme defenses, including HO-1, haptoglobin, hemopexin, and ferritin heavy chain, although plasma hemoglobin and heme levels were unchanged. DMF decreased markers of inflammation, including nuclear factor-kappa B phospho-p65, adhesion molecules, and toll-like receptor 4. DMF administered for 24 weeks to HbSS-Townes mice decreased hepatic necrosis, inflammatory cytokines, and irregularly shaped erythrocytes and increased hemoglobin F, but did not alter hematocrits, reticulocyte counts, lactate dehydrogenase, plasma heme, or spleen weights, indicating that the beneficial effects of DMF were not attributable to decreased hemolysis. Innovation: These studies identify Nrf2 activation as a new therapeutic target for the treatment of SCD. Conclusion: DMF activates Nrf2, enhances antioxidant defenses, and inhibits inflammation and vaso-occlusion in SCD mice. Antioxid. Redox Signal . 26, 748–762.
Relationships between duplex findings and quality of life in long-term follow-up of patients treated for chronic venous disease
Huang, Ying , Gloviczki, Péter , Gloviczki, Péter

Phlebology: The Journal of Venous Disease | February 25, 2016 | Volume: 31 | Issue: 1_suppl | Pages: 88-98

10.1177/0268355516630868 | PMID 26916775 Get It

Objective Relationships between duplex findings and data on health-related quality of life (QoL) to assess long-term results of treatment of varicose veins and chronic venous insufficiency (CVI) are not well known. The goal of this review was to correlate duplex findings and QoL assessments in clinical studies with long-term follow-up. Methods A review of the English language literature on PUBMED revealed 17 clinical studies, including 9 randomized controlled trials (RCTs), 6 prospective, and 2 retrospective studies that included patients with at least 5-year follow-up after endovenous laser ablation (EVLA), radiofrequency ablation (RFA), ultrasound-guided foam sclerotherapy (UGFS), and traditional superficial venous surgery. Results At 5 years, great saphenous vein (GSV) occlusion rate on duplex ultrasound ranged from 66% to 82% for EVLA, from 62% to 92% for RFA, from 41% to 58% for UGFS and from 54% to 85% for surgery. Freedom from GSV reflux rates were 82% and 84%, respectively for EVLA and surgery, and ranged between 84% and 95% for RFA. Significant improvements were observed in several domains of generic QoL and in most domains of venous disease-specific QoL, irrespective of the treatment. In at least one RCT, CIVIQ scores correlated well with abnormal duplex findings in patients who underwent treatment with UGFS. In another RCT, long-term AVVQ was significantly better after surgery as compared with UGFS similar to results of duplex findings. Conclusions Analysis of the available literature confirmed that all four techniques were effective in the abolishment of reflux or obliteration of the GSV. Moreover, well-designed RCTs with large sample size are needed to produce robust long-term data on clinical outcome after treatment of varicose veins and CVI and to better understand the relationships between duplex-derived data and QoL assessments.
Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients
Damlaj, Moussab , Bartoo, Gabriel , Cartin‐Ceba, Rodrigo , Gijima, Desire, Merten, Julianna A., Hashmi, Shahrukh K. , Litzow, Mark R. , Gastineau, Dennis A. , Patnaik, Mrinal M. , Alkhateeb, Hassan B. , Hogan, William J.

Transplant Infectious Disease | February 25, 2016 | Volume: 18 | Issue: 2 | Pages: 216-226

10.1111/tid.12513 | PMID 26909896 Get It

AbstractBackgroundRespiratory syncytial virus (RSV) infection causes significant morbidity and mortality in allogeneic stem cell transplant (allo‐SCT) recipients. Although ribavirin and immunoglobulins are common components of therapy, the role of adjunct corticosteroids is not established.ObjectivesWe sought to evaluate corticosteroid utilization in the setting of post‐allo‐SCT RSV infection in our center and assess post‐transplant outcomes including pulmonary function decline.MethodsPatients with a history of RSV infection from 2008 to 2014 seen at our institution were identified. Treatment and outcome data were retrospectively collected. Forced expiratory volume at 1 s (FEV1) and carbon monoxide diffusion capacity (DLCO) were collected pre‐ and post‐RSV infection.ResultsDuring the observation period, RSV was isolated in 53 of 552 patients undergoing allo‐SCT (10%) and 45 had evaluable therapy data. RSV‐related mortality in this cohort was 4/45 (9%). Twenty‐one (47%) were on corticosteroids prior to RSV diagnosis, of whom 11 (24%) had a dose increase post symptom onset. Eight (18%) patients were started on corticosteroids at the time of RSV infection. Corticosteroid therapy at symptom onset was associated with a higher rate of upper respiratory infection (URTI) to lower respiratory infection (LRTI) progression risk ratio (RR) 2.49 (1.21–5.13; P = 0.016), hospital admission RR 2.05 (1.24–3.37; P = 0.005), or intensive care unit admission RR 2.91 (1.89–5.01; P = 0.002). No significant difference was seen with FEV1 and DLCO decline (P = 0.3 and 0.24, respectively) or mortality (P = 0.26).ConclusionAdjunct corticosteroid use in the setting of RSV infection did not improve RSV‐related outcomes including long‐term pulmonary function. Our results do not support the routine use of corticosteroids; however, this finding does need to be verified in a larger cohort of patients.
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
Li, Lei , Che, Li , Tharp, Kevin M. , Pilo, Maria G., Cao, Dan , Cigliano, Antonio , Latte, Gavinella , Xu, Zhong , Ribback, Silvia , Dombrowski, Frank, Evert, Matthias , Stahl, Andreas , Chen, Xin , Park, Hyo‐Min , Gores, Gregory J. , Calvisi, Diego Francesco

Hepatology | February 25, 2016 | Volume: 63 | Issue: 6 | Pages: 1900-1913

10.1002/hep.28508 | PMID 26910791 Get It

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most prevalent types of primary liver cancer. These malignancies have limited treatment options, resulting in poor patient outcomes. Metabolism reprogramming, including increased de novo lipogenesis, is one of the hallmarks of cancer. Fatty acid synthase (FASN) catalyzes the de novo synthesis of long‐chain fatty acids from acetyl‐coenzyme A and malonyl‐coenzyme A. Increased FASN expression has been reported in multiple tumor types, and inhibition of FASN expression has been shown to have tumor‐suppressing activity. Intriguingly, we found that while FASN is up‐regulated in human HCC samples, its expression is frequently low in human ICC specimens. Similar results were observed in mouse ICC models induced by different oncogenes. Ablating FASN in the mouse liver did not affect activated AKT and Notch (AKT/Notch intracellular domain 1) induced ICC formation in vivo. Furthermore, while both HCC and ICC lesions develop in mice following hydrodynamic injection of AKT and neuroblastoma Ras viral oncogene homolog oncogenes (AKT/Ras), deletion of FASN in AKT/Ras mice triggered the development almost exclusively of ICCs. In the absence of FASN, ICC cells might receive lipids for membrane synthesis through exogenous fatty acid uptake. In accordance with the latter hypothesis, ICC cells displayed high expression of fatty acid uptake‐related proteins and robust long‐chain fatty acid uptake. Conclusion: Our data demonstrate that FASN dependence is not a universal feature of liver tumors: while HCC development is highly dependent of FASN and its mediated lipogenesis, ICC tumorigenesis can be insensitive to FASN deprivation; our study supports novel therapeutic approaches to treat this pernicious tumor type with the inhibition of exogenous fatty acid uptake. (Hepatology 2016;63:1900‐1913)
Distinguishing clinical and radiological features of non‐traumatic convexal subarachnoid hemorrhage
Graff‐Radford, Jonathan , Fugate, Jennifer E. , Klaas, James P. , Flemming, Kelly D. , Brown, R. Dale , Rabinstein, Alejandro A. , Flemming, Kelly D

European Journal of Neurology | February 25, 2016 | Volume: 23 | Issue: 5 | Pages: 839-846

10.1111/ene.12926 | PMID 26910197 Get It

Background and purposeThe full spectrum of causes of convexal subarachnoid hemorrhage (cSAH) requires further investigation. Therefore, our objective was to describe the spectrum of clinical and imaging features of patients with non‐traumatic cSAH.MethodsA retrospective observational study of consecutive patients with non‐traumatic cSAH was performed at a tertiary referral center. The underlying cause of cSAH was characterized and clinical and imaging features that predict a specific etiology were identified. The frequency of future cSAH or intracerebral hemorrhage (ICH) was determined.ResultsIn all, 88 patients [median age 64 years (range 25–85)] with non‐traumatic cSAH were identified. The most common causes were reversible cerebral vasoconstriction syndrome (RCVS) (26, 29.5%), cerebral amyloid angiopathy (CAA) (23, 26.1%), indeterminate (14, 15.9%) and endocarditis (9, 10.2%). CAA patients commonly presented at an older age than RCVS patients (75 years versus 51 years, P < 0.0001). Thirteen patients (14.7%) had recurrent cSAH, and 12 patients (13.6%) had a subsequent ICH. However, the risk was high amongst those with CAA compared to those caused by RCVS, with recurrent cSAH in 39.1% and subsequent lobar ICH in 43.5% of CAA cases.ConclusionsOur study demonstrates the clinical diversity of cSAH. Older age, sensorimotor dysfunction and stereotyped spells suggest CAA as the underlying cause. Younger age and thunderclap headache predict RCVS. Yet, various other causes also need to be considered in the differential diagnosis.